In: PATENT NEWS
Pivot Technology Solutions, Inc. Secures United States Patent for Smart Edge Yahoo Finance TORONTO , June 21, 2019 /CNW/ – Pivot Technology Solutions, Inc. (PTG.TO), (“Pivot”), a full-*service* information technology provider, today announced that the …
In: PATENT NEWS
Immutep Announces Australian Patent Granted for Eftilagimod Alpha in Chemo-Immunotherapy Nasdaq SYDNEY, Australia, June 21, 2019– Immutep Limited, a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune.
In: PATENT NEWS
Microsoft patent shows Surface Pen with OLED display HEXUS It could provide various status and mode indicators, show notifications, and more.
In: PATENT NEWS
Patent initiative for SMES seeks funding from EU World Intellectual Property Review A new initiative, Patent Factory Europe, which aims to boost the competitiveness of European small and medium-sized enterprises (SMEs), is seeking funding …
In: PATENT NEWS
Consequences of the French PACTE Act in Terms of Patent Rights Lexology The Background: The Action Plan for the Growth and Transformation of Enterprises Act (“PACTE Act”) adopted on April 11, 2019 and promulgated…
In: PATENT NEWS
Huawei foldable phone patent reveals a Samsung Galaxy Fold-like rival TechRadar A recent patent shows Huawei considered a revamped version of the Mate X that folds inwards, instead of outwards.
In: PATENT NEWS
New patents for innovative facial cleansers Cosmetics Business This issue’s patents focus on skin cleansing concepts from antibacterial and anti-acne soaps to washes that deposit sunscreen on the skin.
In: PATENT NEWS
Broad claim language may render patent invalid under obviousness Lexology In BTG Int’l Ltd. v. Amneal Pharms. LLC (Fed. Cir. May 14, 2019), the Federal Circuit affirmed the decisions of the Patent Trial and Appeal Board…
In: PATENT NEWS
“Statutory” Obviousness-Type Double Patenting for Pharma Patents? Lexology As all patent practitioners know, obviousness-type double patenting is a judicially created doctrine to prevent the unjust extension of patent term…
In: PATENT NEWS
After a pharma lobbying blitz, Congress softens legislation on drug patents STAT Pharmaceutical companies appear to have succeeded in watering down legislation that would’ve made it harder for them to accumulate patents.
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION